Rhenman & Partners Asset Management’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-90,600
Closed -$3.83M 95
2018
Q1
$3.83M Sell
90,600
-5,000
-5% -$215K 0.47% 61
2017
Q4
$5.12M Sell
95,600
-53,660
-36% -$2.83M 0.69% 53
2017
Q3
$6.66M Sell
149,260
-8,240
-5% -$375K 0.85% 46
2017
Q2
$7.66M Sell
157,500
-2,500
-2% -$147K 1.1% 34
2017
Q1
$11.6M Buy
160,000
+102,500
+178% +$6.78M 1.83% 16
2016
Q4
$3.29M Buy
57,500
+14,000
+32% +$1.28M 0.63% 58
2016
Q3
$5.57M Hold
43,500
0.88% 40
2016
Q2
$5.42M Hold
43,500
0.96% 40
2016
Q1
$3.64M Buy
43,500
+1,500
+4% +$124K 0.72% 53
2015
Q4
$4.16M Buy
42,000
+19,100
+83% +$2.05M 0.63% 56
2015
Q3
$2.81M Buy
22,900
+5,000
+28% +$679K 0.45% 66
2015
Q2
$2.75M Sell
17,900
-1,500
-8% -$248K 0.33% 87
2015
Q1
$3.31M Hold
19,400
0.56% 61
2014
Q4
$2.97M Sell
19,400
-600
-3% -$74.9K 0.86% 42
2014
Q3
$2.12M Sell
20,000
-500
-2% -$69.7K 0.62% 61
2014
Q2
$3.12M Buy
20,500
+316
+2% +$42.1K 0.93% 34
2014
Q1
$2.6M Buy
20,184
+12,081
+149% +$1.88M 0.78% 48
2013
Q4
$1.41M Buy
+8,103
New +$1.39M 0.55% 71

Other funds holding ELGX

Rhenman & Partners Asset Management's ELGX Position: Q2 2018 in Review

Rhenman & Partners Asset Management sold out of Endologix Inc (ELGX) in Q2 2018, closing a stake of 90,600 shares — an estimated $3.83M sold.

Rhenman & Partners Asset Management first reported a position in ELGX in Q4 2013 and held it in 18 quarters. The position peaked at $11.6M in Q1 2017. 107 funds tracked by Wall St. Rank hold ELGX as of Q2 2018.

  • Rhenman & Partners Asset Management reported no remaining Endologix Inc position as of Q2 2018 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 90,600 Endologix Inc shares in Q2 2018, an estimated $3.83M.
  • Rhenman & Partners Asset Management first reported a position in Endologix Inc in Q4 2013 and held it in 18 quarters.
  • Rhenman & Partners Asset Management's Endologix Inc position peaked at $11.6M in Q1 2017.
  • 107 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2018.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2018, filed 20 Jul 2018.